Engineering strategies for improving CART therapy against cancer

The STOP CART design and the coexpression of IL-5 with CAR, as discussed in this presentation, are interesting.

Further reading:

https://pubmed.ncbi.nlm.nih.gov/33156338/

https://www.sciencedirect.com/science/article/pii/S0958166920300094